On June 10, 2026, the U.S. Food and Drug Administration (FDA) issued Final Administrative Order OTC000039, officially amending Over-the-Counter (OTC) Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use to add bemotrizinol as a permitted active ingredient.
Original regulatory document
Request a Demo
